{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:58:10Z","timestamp":1791197890844,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006727","name":"The University of Kansas Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaci.2026.06.022","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:56:27Z","timestamp":1787198187000},"page":"1156-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet-macrophage cross talk in IL-33\u2013driven type 2 lung inflammation: Advances, gaps, and future directions"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6742-3460","authenticated-orcid":false,"given":"Isaac Kirubakaran","family":"Sundar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.06.022_bib1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2025.12.1012","article-title":"Platelet-macrophage cooperation drives IL-33-dependent type 2 lung immunopathology in a sex-biased manner","volume":"157","author":"Hayashi","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.022_bib2","doi-asserted-by":"crossref","first-page":"Ab172","DOI":"10.1016\/j.jaci.2014.12.1498","article-title":"Leukotriene C4 potentiates IL-33-induced ILC2 activation and lung inflammation through CysLT1R","volume":"135","author":"Lund","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.022_bib3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaci.2016.01.032","article-title":"Platelets constitutively express IL-33 protein and modulate eosinophilic airway inflammation","volume":"138","author":"Takeda","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.022_bib4","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3389\/fimmu.2017.01618","article-title":"Promoter specificity and efficacy in conditional and inducible transgenic targeting of lung macrophages","volume":"8","author":"McCubbrey","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.06.022_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126556","article-title":"Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets","volume":"4","author":"Mould","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2026.06.022_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2025.11.015","article-title":"Innate type 2 lymphocytes trigger an inflammatory switch in alveolar macrophages","volume":"59","author":"Verwaerde","year":"2026","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.06.022_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk1673","article-title":"Epidermal growth factor receptor controls sex differences in lung type 2 responses to inhaled allergen","volume":"11","author":"Stolting","year":"2026","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.06.022_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7150\/ijms.91253","article-title":"Combination of androgen and estrogen improves asthma by mediating Runx3 expression","volume":"21","author":"He","year":"2024","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jaci.2026.06.022_bib9","article-title":"Chronic HDM exposure shows time-of-day and sex-based differences in inflammatory response associated with lung circadian clock disruption","volume":"26","author":"Srinivasan","year":"2023","journal-title":"iSscience"},{"key":"10.1016\/j.jaci.2026.06.022_bib10","article-title":"Acute HDM exposure shows time-of-day and sex-based differences in the severity of lung inflammation and circadian clock disruption","volume":"2","author":"Srinivasan","year":"2023","journal-title":"J Allergy Clin Immunol Glob"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:58:14Z","timestamp":1791194294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926004926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0091674926004926"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.022","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-macrophage cross talk in IL-33\u2013driven type 2 lung inflammation: Advances, gaps, and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.12.1012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}